Folgen
Nicole M. Bouvier
Nicole M. Bouvier
Bestätigte E-Mail-Adresse bei mssm.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
The biology of influenza viruses
NM Bouvier, P Palese
Vaccine 26, D49-D53, 2008
16252008
Aerosol emission and superemission during human speech increase with voice loudness
S Asadi, AS Wexler, CD Cappa, S Barreda, NM Bouvier, WD Ristenpart
Scientific reports 9 (1), 1-10, 2019
10772019
The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles?
S Asadi, N Bouvier, AS Wexler, WD Ristenpart
Aerosol Science and Technology 54 (6), 635-638, 2020
8342020
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
STH Liu, HM Lin, I Baine, A Wajnberg, JP Gumprecht, F Rahman, ...
Nature medicine 26 (11), 1708-1713, 2020
5272020
Animal models for influenza virus pathogenesis and transmission
NM Bouvier, AC Lowen
Viruses 2 (8), 1530-1565, 2010
4662010
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins
MS Park, ML Shaw, J Munoz-Jordan, JF Cros, T Nakaya, N Bouvier, ...
Journal of virology 77 (2), 1501-1511, 2003
4562003
Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities
S Asadi, CD Cappa, S Barreda, AS Wexler, NM Bouvier, WD Ristenpart
Scientific reports 10 (1), 1-13, 2020
3942020
Environmental factors affecting the transmission of respiratory viruses
N Pica, NM Bouvier
Current opinion in virology 2 (1), 90-95, 2012
3162012
The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis
SA Klassen, JW Senefeld, PW Johnson, RE Carter, CC Wiggins, ...
Mayo Clinic Proceedings 96 (5), 1262-1275, 2021
246*2021
Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study
A Wajnberg, M Mansour, E Leven, NM Bouvier, G Patel, ...
The Lancet Microbe 1 (7), e283-e289, 2020
237*2020
Animal models for influenza virus pathogenesis, transmission, and immunology
RR Thangavel, NM Bouvier
Journal of immunological methods 410, 60-79, 2014
2212014
Influenza A virus transmission bottlenecks are defined by infection route and recipient host
A Varble, RA Albrecht, S Backes, M Crumiller, NM Bouvier, D Sachs, ...
Cell host & microbe 16 (5), 691-700, 2014
2132014
Effect of voicing and articulation manner on aerosol particle emission during human speech
S Asadi, AS Wexler, CD Cappa, S Barreda, NM Bouvier, WD Ristenpart
PloS one 15 (1), e0227699, 2020
2032020
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility
R Hai, M Schmolke, VH Leyva-Grado, RR Thangavel, I Margine, EL Jaffe, ...
Nature communications 4 (1), 2854, 2013
1822013
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins
R Nachbagauer, A Choi, A Hirsh, I Margine, S Iida, A Barrera, M Ferres, ...
Nature immunology 18 (4), 464-473, 2017
1542017
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation
A Rialdi, L Campisi, N Zhao, AC Lagda, C Pietzsch, JSY Ho, ...
Science 352 (6289), aad7993, 2016
1522016
Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol
NM Bouvier, AC Lowen, P Palese
Journal of virology 82 (20), 10052-10058, 2008
1102008
Individuals with Down syndrome hospitalized with COVID-19 have more severe disease
L Malle, C Gao, C Hur, HQ Truong, NM Bouvier, B Percha, XF Kong, ...
Genetics in Medicine 23 (3), 576-580, 2021
107*2021
An amphibian host defense peptide is virucidal for human H1 hemagglutinin-bearing influenza viruses
DJ Holthausen, SH Lee, VTV Kumar, NM Bouvier, F Krammer, ...
Immunity 46 (4), 587-595, 2017
1042017
Influenza A virus is transmissible via aerosolized fomites
S Asadi, N Gaaloul ben Hnia, RS Barre, AS Wexler, WD Ristenpart, ...
Nature communications 11 (1), 4062, 2020
1022020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20